Verantos has been recognized as the 444th fastest-growing technology company in North America on the 2025 Deloitte Technology Fast 500™, a prestigious ranking that celebrates the top 500 high-growth technology, media, telecommunications, life sciences, fintech, and energy tech companies across the region. Now in its 31st year, the list highlights companies that have achieved exceptional revenue growth over the past three years. Verantos, a leader in real-world evidence (RWE) solutions, stands out as the only company on the list focused exclusively on generating and leveraging real-world data to inform healthcare decisions. The company’s inclusion underscores its rapid expansion and growing influence in the healthcare technology sector. “Real-world evidence is increasingly used to augment clinical trial results, offering valuable insights into patient subgroups, treatment effectiveness, and long-term outcomes in diverse populations,” said Verantos’ chief executive. “Our ability to deliver timely, reliable, and actionable RWE has been central to our growth and our mission to transform how healthcare decisions are made.” The company’s success is driven by its advanced data analytics platform, which aggregates and analyzes data from electronic health records, insurance claims, and other real-world sources. This enables pharmaceutical companies, regulators, and healthcare providers to make more informed decisions about drug development, patient care, and policy. Verantos’ strong performance on the Deloitte list reflects not only its financial growth but also its ability to scale its technology and services in response to rising demand for real-world data. As the healthcare industry places greater emphasis on evidence-based decision-making, Verantos is well-positioned to continue its momentum.